Efficacy Study of Integrated TCM Combined With Chemotherapy in Postoperative NSCLC Patients
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The investigators performed a multi-center, randomized, controlled, double-blind, prospective
study on evaluating effect of chemotherapy combined with or without integrated TCM on quality
of life (QOL) of postoperative Non-small Cell Lung Cancer (NSCLC) patients. The investigators
plan to involve 600 cases for observation in 3 years (300 cases for each group), expecting
that QOL of postoperative NSCLC patients can be improved by integrated TCM combined with
chemotherapy compared to that by chemotherapy alone.